Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Patients with acute ischemic stroke
- Patients with fire-heat syndrome
- Stoke onset within 48 hours
- NIHSS scores range from 5 points to 25 points
- Age from forty to seventy-five,gender not limited
- Informed and signed the consent

Exclusion Criteria

- Cardiogenic cerebral embolism,stroke caused by other reasons or the unexplained
- Patients suitable for thrombolytic therapy(rt-PA, urokinase)
- Patients have received thrombolytic therapy
- Patients with serious diseases of heart,lungs,liver,kidneys
- Patients with bleeding or bleeding tendency recently
- Pregnant or lactating women
- Pre-existing neurological or psychiatric diseases that could confound the study results
- Patients be allergic to alcohol,Ixeris of sonchifolia Hance components (KDZ injection) or Panax notoginseng saponins components (Xueshuantong injection)
- Patients have participated in other clinical trials within 3 months